Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open
NEW YORK, Dec. 28, 2025, 6:44 a.m. ET — Market closed Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) heads into the final trading days of 2025 with investors trying to separate two very different realities: an explosive year-to-date run that put the breast-cancer biotech firmly on the growth-stock map—and a sharp late-December pullback that has reset near-term expectations. With U.S. markets closed for the weekend and set to reopen Monday, December 29, traders will be watching whether OLMA can stabilize after Friday’s decline and whether fresh headlines (or filings) emerge that could shift sentiment in either direction. Where OLMA stands heading into